UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 5 von 93
Datensatz exportieren als...
BibTeX
A Novel Domain‐Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone
Journal of bone and mineral research, 2016-04, Vol.31 (4), p.874-881
Fijalkowski, Igor
Geets, Ellen
Steenackers, Ellen
Van Hoof, Viviane
Ramos, Feliciano J
Mortier, Geert
Fortuna, Ana Maria
Van Hul, Wim
Boudin, Eveline
2016
Details
Autor(en) / Beteiligte
Fijalkowski, Igor
Geets, Ellen
Steenackers, Ellen
Van Hoof, Viviane
Ramos, Feliciano J
Mortier, Geert
Fortuna, Ana Maria
Van Hul, Wim
Boudin, Eveline
Titel
A Novel Domain‐Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone
Ist Teil von
Journal of bone and mineral research, 2016-04, Vol.31 (4), p.874-881
Ort / Verlag
United States: Wiley Subscription Services, Inc
Erscheinungsjahr
2016
Link zum Volltext
Quelle
Wiley Blackwell Single Titles
Beschreibungen/Notizen
ABSTRACT Mutations in the LRP4 gene, coding for a Wnt signaling coreceptor, have been found to cause several allelic conditions. Among these, two are characterized by a strong skeletal involvement, namely sclerosteosis and Cenani‐Lenz syndrome. In this work, we evaluated the role of LRP4 in the pathophysiology of these diseases. First, we report a novel LRP4 mutation, leading to the substitution of arginine at position 1170 in glutamine, identified in a patient with sclerosteosis. This mutation is located in the central cavity of the third β‐propeller domain, which is in line with two other sclerosteosis mutations we previously described. Reporter assays demonstrate that this mutation leads to impaired sclerostin inhibition of Wnt signaling. Moreover, we compared the effect of this novel variant to mutations causing Cenani‐Lenz syndrome and show that impaired membrane trafficking of the LRP4 protein is the likely mechanism underlying Cenani‐Lenz syndrome. This is in contrast to sclerosteosis mutations, previously shown to impair the binding between LRP4 and sclerostin. In addition, to better understand the biology of LRP4, we investigated the circulating sclerostin levels in the serum of a patient suffering from sclerosteosis owing to a LRP4 mutation. We demonstrate that impaired sclerostin binding to the mutated LRP4 protein leads to dramatic increase in circulating sclerostin in this patient. With this study, we provide the first evidence suggesting that LRP4 is responsible for the retention of sclerostin in the bone environment in humans. These findings raise potential concerns about the utility of determining circulating sclerostin levels as a marker for other bone‐related parameters. Although more studies are needed to fully understand the mechanism whereby LRP4 facilitates sclerostin action, it is clear that this protein represents a potent target for future osteoporosis therapies and an interesting alternative for the antisclerostin treatment currently under study. © 2016 American Society for Bone and Mineral Research.
Sprache
Englisch
Identifikatoren
ISSN: 0884-0431
eISSN: 1523-4681
DOI: 10.1002/jbmr.2782
Titel-ID: cdi_proquest_miscellaneous_1785248343
Format
–
Schlagworte
Amino Acid Substitution
,
ANABOLICS
,
Bone Morphogenetic Proteins - genetics
,
Bone Morphogenetic Proteins - metabolism
,
Genetic Markers - genetics
,
HEK293 Cells
,
Humans
,
Hyperostosis - genetics
,
Hyperostosis - metabolism
,
LDL-Receptor Related Proteins - genetics
,
LDL-Receptor Related Proteins - metabolism
,
LRPs
,
Mutation, Missense
,
Protein Binding
,
Protein Domains
,
SCLEROSTEOSIS
,
Syndactyly - genetics
,
Syndactyly - metabolism
,
WNT
,
β‐CATENIN
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX